My Locations
Gary C. Werths Building at Siteman Cancer Center
Expertise & Training
Angela Hirbe, MD, PhD
2 minsWashington University medical oncologist, Angela Hirbe, MD, PhD, discusses what patients with sarcomas and rare tumors can expect from their extended care team at Siteman Cancer Center. Learn more about Dr. Hirbe: https://siteman.wustl.edu/doctor/hirbe-angela/
Learn more about the Siteman Approach to Sarcoma/Rare Tumors: https://siteman.wustl.edu/treatment/cancer-types/sarcoma/our-approach/
Learn more about extremity sarcoma treatments: https://siteman.wustl.edu/treatment/cancer-types/sarcoma/musculoskeletal-extremity-treatments/
Learn more about nonextremity sarcoma treatments: https://siteman.wustl.edu/treatment/cancer-types/sarcoma/nonextremity-treatments/
Clinical Expertise
As the director of our sarcoma specialist team, Dr. Hirbe cares for patients diagnosed with sarcomas and rare tumors through treatment and recovery. Learn more about how Dr. Hirbe and Siteman approach extremity and non-extremity sarcoma treatment and recovery.
Primary Academic Title
Associate Professor of Medicine and Pediatrics Director, Sarcoma Program Co-Director AYA Sarcoma Program Director, Adult Neurofibromatosis Clinical Program
Board Certification
- 2012: American Board of Internal Medicine
Training
- 2009 - 2011: Resident, Internal Medicine, WashU Medicine, St. Louis, MO
- 2011 - 2012: Chief Resident, Internal Medicine, WashU Medicine, St. Louis, MO
- 2012 - 2016: Hematology and Oncology Fellow, Postdoctoral Research Fellow, WashU Medicine, St. Louis, MO
Education
- 2009: MD, PhD, Washington University of Medicine, St. Louis, MO
Research & Selected Publications
Research Interest
Utilize genomic information from human sarcoma to better understand the development and progression of these cancers in order to identify biomarkers and therapeutic targets. The pathogenesis of malignant peripheral nerve sheath tumors (MPNSTs), an aggressive soft tissue sarcoma that occurs at an increased frequency in patients with the Neurofibromatosis Type 1 (NF1) tumor predisposition syndrome.
Research Publications